KRAS and gastric cancer: The Cancer Genome Atlas Research Network [5] and the Asian Cancer Research Group [6] found activating mutations in KRAS to be present in gastric cancer tumors, particularly in 25% of microsatellite-instable (MSI) subtypes of gastric cancer.